Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2005
08/04/2005US20050169853 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with Porphyromonas gingivalis
08/04/2005US20050169848 useful for enhancing immune response to antigens; vaccines; applicable to mucosal immunization in humans
08/04/2005US20050166338 Kit for promoting the growth of human hair and its method of use
08/04/2005CA2554472A1 Lawsonia intracellularis subunit vaccines
08/04/2005CA2553986A1 Adjuvant compositions
08/04/2005CA2553883A1 Anti-cancer antibodies with reduced complement fixation
08/04/2005CA2553854A1 Immunomodulatory alkaloids
08/04/2005CA2553756A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications
08/04/2005CA2553541A1 Chimpanzee adenovirus vaccine carriers
08/04/2005CA2553221A1 Folate conjugates and complexes
08/04/2005CA2552891A1 Regulatory t cells suppress autoimmunity
08/04/2005CA2552788A1 Fc region variants
08/04/2005CA2552328A1 Non-animal origin stabilizers and processes for producing the same
08/04/2005CA2551644A1 Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of usethereof
08/04/2005CA2547757A1 Monoparamunity inducers based on attenuated rabbit myxoma viruses
08/03/2005EP1560025A2 Specific markers for diabetes
08/03/2005EP1559795A2 Neisseria genomic sequences and methods of their use
08/03/2005EP1559726A2 Growth differentiation factor-10
08/03/2005EP1559725A1 Antigen recognizing antibody
08/03/2005EP1559432A1 Hm1.24-utilizing cancer vaccines
08/03/2005EP1559328A1 Fungal feeds for aquaculture and agriculture
08/03/2005EP1559327A1 Bacterial feeds for aquaculture and agriculture
08/03/2005EP1558766A2 Use of a33 antigens and jam-it
08/03/2005EP1558749A2 Atypical protein kinase c isoforms in disorders of the nervous system and cancer
08/03/2005EP1558740A2 Recombinant protein variants
08/03/2005EP1558726A1 Vaccines against west nile virus
08/03/2005EP1558650A2 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
08/03/2005EP1558649A1 Peptides modulating caspase activation
08/03/2005EP1558647A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
08/03/2005EP1558646A2 Single domain antibodies directed against interferon- gamma and uses thereof
08/03/2005EP1558645A2 Stabilized single domain antibodies
08/03/2005EP1558636A2 Vaccine
08/03/2005EP1558635A2 Vaccine
08/03/2005EP1558634A2 Ebv vaccine using gp350 antigen
08/03/2005EP1558628A1 Antigenic peptides
08/03/2005EP1558286A2 Assay for autoantibodies to folate receptors
08/03/2005EP1558285A1 Method for decreasing depression by inhibiting the activity of n-type calcium channel
08/03/2005EP1558284A1 Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents
08/03/2005EP1558283A2 Hcv vaccine compositions comprising e1 and ns3 peptides
08/03/2005EP1558282A2 Anti-cancer and anti-infectious disease compositions and methods for using same
08/03/2005EP1558280A2 Compositions and methods for treating or preventing pneumococcal infection
08/03/2005EP1558276A2 Flaviviris fusion inhibitors
08/03/2005EP1558085A1 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer
08/03/2005EP1267899B1 Ssa inactivated salmonella vaccines
08/03/2005EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof
08/03/2005EP1140106B1 Treatment of diseases involving cyst formation
08/03/2005EP1123710B1 Freeze-dried hepatitis a attenuated live vaccine and its stabilizer
08/03/2005EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip)
08/03/2005EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
08/03/2005EP0742834B2 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
08/03/2005EP0702722B1 Plasmids suitable for gene therapy
08/03/2005CN1650015A DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
08/03/2005CN1650014A Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
08/03/2005CN1650013A DNA vaccines against hantavirus infections
08/03/2005CN1650012A Antigens encoded by alternative reading frame from pathogenic viruses
08/03/2005CN1650011A Methods and compositions for treating neoplasms by ERBB3
08/03/2005CN1649901A Specific antibody fragments for the human carcinoembryonic antigen (cea)
08/03/2005CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
08/03/2005CN1649898A Novel peptides and the application thereof in therapy
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649894A A method for identification, isolation and production of antigens to a specific pathogen
08/03/2005CN1649890A Anti-protozoal vaccine
08/03/2005CN1649625A Conjugates of therapeutic or cytotoxic agents and biologically active peptides
08/03/2005CN1649624A Use of TNF alpha antibodies and another drug
08/03/2005CN1649623A Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
08/03/2005CN1649622A DNA vaccine against proliferating endothelial cells and methods of use thereof
08/03/2005CN1649618A Methods
08/03/2005CN1647823A Sars冠状病毒全病毒疫苗 Sars coronavirus whole virus vaccine
08/03/2005CN1647822A Poliomyelitis inactivated vaccine and its preparing method
08/03/2005CN1647821A Method for preparing specific nano vaccine for stomach cancer
08/03/2005CN1213145C Modified EB virus LMP1 coding sequence and its prepn and application
08/03/2005CN1213070C Monoclonal antibodies directed against the G3BP protein and use
08/03/2005CN1213068C Improvments in or relating to immune responses to HIV
08/02/2005US6924415 Identified as a target for therapeutic intervention due to its role in molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy
08/02/2005US6924362 Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
08/02/2005US6924360 Antitumor agents
08/02/2005US6924266 NTP-peptides and method for removal of tumors
08/02/2005US6924141 Inducing the effects of promoted signal transduction with protein and lithium chloride or mimicking via administration of agent that inhibits either catenin phosphorylation or kinase
08/02/2005US6924137 virus is propagated in culture media at a cultivation temperature below 37 degrees C., wherein the chordopoxvirus is selected from Avipoxvirus and modified vaccinia virus Ankara
08/02/2005US6924135 DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
08/02/2005US6924121 Sperm specific proteins
08/02/2005US6924118 Recombinant intracellular pathogen immunogenic compositions and methods for use
08/02/2005US6924117 Human RRP sequences and methods of use
08/02/2005US6924095 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
08/02/2005US6923973 such as coccidioidomycosis and Valley Fever
08/02/2005US6923972 Methods for use of genetically modified tumor-targeted bacteria with reduced virulence
08/02/2005US6923971 Vaccines
08/02/2005US6923970 Retrovirus-like particles made non-infectious by a plurality of mutations
08/02/2005US6923969 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine
08/02/2005US6923964 amyloid fibrils; for preventing/treating amyloid diseases/Alzheimer's disease
08/02/2005US6923963 Diagnosis of ehrlichia canis and ehrlichia chaffeensis
08/02/2005US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation
08/02/2005US6923958 For immunizing a mammal against cancer cells that present a carcinoembryonic antigen (CEA)
08/02/2005US6923957 Inactivated virulence genes
08/02/2005US6923951 Non-invasive localization of a light-emitting conjugate in a mammal
08/02/2005CA2275033C Biodegradable targetable microparticle delivery system
08/02/2005CA2169297C Protein- or peptide-cochleate vaccines and methods of immunizing using the same
07/2005
07/30/2005CA2495497A1 Compositions for eliciting immune response and methods for using same
07/28/2005WO2005068639A2 Particle-induced ghrelin immune response
07/28/2005WO2005068634A1 Hiv-1 indian subtype c vaccine constructs for use in humans
1 ... 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 ... 1823